The COVID-19 pandemic is disrupting almost every aspect of life in some way. Clinical trials are no exception, and many researchers are concerned that their studies may be delayed or paused indefinitely as the pandemic progresses.

In this webinar, Derk Arts, MD, PhD, CEO of Castor, and Baljit (Boo) Samra, Strategic Advisor and former COO of Duke Clinical Research Institute, shared

  1. Insights on how to continue moving your research forward during this pandemic.
  2. Tips on how to ensure research continuity during COVID-19 by running your trial with a more decentralized approach.

Share article